
|Poll|September 29, 2015
"Up the Price by How Much?"
Author(s)Consultantlive Staff
Turing Pharmaceutical's CEO has backed down on the 4000% price hike for Daraprim, but is the damage done? Take our poll.
Advertisement
You’ve read about Turing Pharmaceuticals’ recent attempt to increase the cost of Daraprim by about 4000%.
Do you think this move is:
Advertisement
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Approves SimpleScreen CRC Blood Test for Colorectal Cancer Screening
2
Bepirovirsen and the Push to Close Hepatitis B Care Gaps
3
Noninvasive Testing and the Colorectal Cancer Screening Gap, With Mark Fendrick, MD
4
FDA Grants Fast Track Designation to HTX-001 for Symptomatic Nonobstructive Hypertrophic Cardiomyopathy
5





























































































































































